Evelo Biosciences (EVLO) Competitors $0.0005 0.00 (0.00%) As of 09/3/2025 03:35 PM Eastern Add Compare Share Share Competitors Stock AnalysisChartCompetitorsInsider TradesSEC FilingsShort InterestTrendsBuy This Stock EVLO vs. SMFL, SCPS, VRPX, STAB, CMRA, GNCAQ, GNCA, ARDS, AMPE, and PXMDShould you be buying Evelo Biosciences stock or one of its competitors? The main competitors of Evelo Biosciences include Smart for Life (SMFL), Scopus BioPharma (SCPS), Virpax Pharmaceuticals (VRPX), Statera Biopharma (STAB), Comera Life Sciences (CMRA), Genocea Biosciences (GNCAQ), Genocea Biosciences (GNCA), Aridis Pharmaceuticals (ARDS), Ampio Pharmaceuticals (AMPE), and PaxMedica (PXMD). These companies are all part of the "pharmaceutical products" industry. Evelo Biosciences vs. Its Competitors Smart for Life Scopus BioPharma Virpax Pharmaceuticals Statera Biopharma Comera Life Sciences Genocea Biosciences Genocea Biosciences Aridis Pharmaceuticals Ampio Pharmaceuticals PaxMedica Smart for Life (NASDAQ:SMFL) and Evelo Biosciences (NASDAQ:EVLO) are both small-cap medical companies, but which is the superior business? We will compare the two companies based on the strength of their media sentiment, analyst recommendations, earnings, risk, profitability, institutional ownership, dividends and valuation. Does the media prefer SMFL or EVLO? In the previous week, Evelo Biosciences had 1 more articles in the media than Smart for Life. MarketBeat recorded 1 mentions for Evelo Biosciences and 0 mentions for Smart for Life. Smart for Life's average media sentiment score of 0.00 equaled Evelo Biosciences'average media sentiment score. Company Overall Sentiment Smart for Life Neutral Evelo Biosciences Neutral Which has more risk & volatility, SMFL or EVLO? Smart for Life has a beta of 17.06, indicating that its stock price is 1,606% more volatile than the S&P 500. Comparatively, Evelo Biosciences has a beta of 0.85, indicating that its stock price is 15% less volatile than the S&P 500. Do insiders and institutionals hold more shares of SMFL or EVLO? 28.4% of Smart for Life shares are owned by institutional investors. Comparatively, 0.3% of Evelo Biosciences shares are owned by institutional investors. 31.7% of Smart for Life shares are owned by company insiders. Comparatively, 1.0% of Evelo Biosciences shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock is poised for long-term growth. Which has better valuation and earnings, SMFL or EVLO? Smart for Life has higher revenue and earnings than Evelo Biosciences. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioSmart for Life$11.11M0.00-$22.68MN/AN/AEvelo BiosciencesN/AN/A-$114.53MN/AN/A Is SMFL or EVLO more profitable? Company Net Margins Return on Equity Return on Assets Smart for LifeN/A N/A N/A Evelo Biosciences N/A N/A N/A SummarySmart for Life beats Evelo Biosciences on 5 of the 6 factors compared between the two stocks. Get Evelo Biosciences News Delivered to You Automatically Sign up to receive the latest news and ratings for EVLO and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding EVLO and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip Chart EVLO vs. The Competition Export to ExcelMetricEvelo BiosciencesPharmaceutical IndustryMedical SectorNASDAQ ExchangeMarket Cap$9K$865.53M$5.77B$9.91BDividend YieldN/A4.84%6.67%4.51%P/E RatioN/A1.1475.7426.65Price / SalesN/A26.53557.21121.56Price / CashN/A19.5637.1158.92Price / BookN/A6.7711.446.07Net Income-$114.53M-$4.20M$3.28B$266.32M7 Day PerformanceN/A0.23%0.63%0.06%1 Month PerformanceN/A10.24%6.89%3.90%1 Year PerformanceN/A26.47%59.40%23.68% Evelo Biosciences Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)EVLOEvelo BiosciencesN/A$0.00flatN/AN/A$9KN/A0.00120Options VolumeSMFLSmart for LifeN/A$0.00+33.3%N/A-96.6%$31K$11.11M0.00110Gap UpSCPSScopus BioPharmaN/A$0.00+66.7%N/AN/A$21KN/A0.009VRPXVirpax Pharmaceuticals0.1019 of 5 stars$0.01-9.8%N/A-99.9%$14KN/A0.007STABStatera BiopharmaN/A$0.00+100.0%N/A-83.3%$11KN/A0.0020Gap UpHigh Trading VolumeCMRAComera Life SciencesN/A$0.00flatN/AN/A$6K$1.00M0.002GNCAQGenocea BiosciencesN/AN/AN/AN/A$6KN/A0.0070GNCAGenocea BiosciencesN/AN/AN/AN/A$6K$1.91M0.0070ARDSAridis PharmaceuticalsN/AN/AN/AN/A$5KN/A0.0030Gap DownAMPEAmpio PharmaceuticalsN/A$0.00flatN/A+22.7%$3KN/A0.0020PXMDPaxMedicaN/A$0.00flatN/AN/A$2KN/A0.002 Related Companies and Tools Related Companies SMFL Alternatives SCPS Alternatives VRPX Alternatives STAB Alternatives CMRA Alternatives GNCAQ Alternatives GNCA Alternatives ARDS Alternatives AMPE Alternatives PXMD Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:EVLO) was last updated on 9/5/2025 by MarketBeat.com Staff From Our PartnersWhy Trump’s “Smart Dollar” could rewrite the rulesMUST SEE: Donald Trump's Radical Overhaul of the U.S. Dollar Congress just approved President Trump's lates...Stansberry Research | Sponsored“Sell Nvidia before earnings”Eric Fry just went live with one of his most controversial calls yet: “Sell Nvidia.” While Wall Street has bee...InvestorPlace | SponsoredHow “Trump’s New Dollar” Could Impact Your WealthPresident Trump just signed a game-changing law… That could soon upgrade the U.S. dollar in your checking a...Brownstone Research | SponsoredForget Tesla — This Tiny AI Stock Is Musk’s Real PlayWhile Wall Street focused on Tesla’s earnings, Elon Musk was quietly building a supercomputer so powerful it c...Behind the Markets | SponsoredRetire Comfortably with These New Monthly Income ETFs?Too many retirees lie awake at night, worried their savings won’t last. Traditional advice and tiny returns ju...Investors Alley | SponsoredWhat's the Best Way to Lower RMD Taxes?Turning 73 triggers a key IRS rule: you must begin taking required minimum distributions (RMDs) from certain r...SmartAsset | SponsoredWarren Buffett Issues Cryptic Warning on U.S. DollarImagine a bull market so powerful, every single investor became a millionaire. Not by finding the next NVIDIA ...Banyan Hill Publishing | SponsoredOne tiny company just cracked Google’s $19B problemFor decades, this “AI metal” was trapped in labs, too slow and expensive to ever reach mass production. The...True Market Insiders | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Evelo Biosciences, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Evelo Biosciences With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
